Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma
2018 · New England Journal of Medicine · 3,889 citations
https://doi.org/10.1056/nejmoa1804980
H
Harald Holte
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
442
Papers
27.8K
Citations
58
h-index
198
i10-index
Harald Holte is an academic researcher from Oslo University Hospital. The author has contributed to research in topics: Lymphoma Diagnosis and Treatment & CAR-T cell therapy research & Chronic Lymphocytic Leukemia Research. The author has an h-index of 58, co-authored 376 publications.
ORCID: 0000-0001-9799-9428Papers by this author
worksStromal Gene Signatures in Large-B-Cell Lymphomas
2008 · New England Journal of Medicine · 1,797 citations
https://doi.org/10.1056/nejmoa0802885
Valvular dysfunction and left ventricular changes in Hodgkin's lymphoma survivors. A longitudinal study
2009 · British Journal of Cancer · 116 citations
https://doi.org/10.1038/sj.bjc.6605191
Socio-medical situation for long-term survivors of Hodgkin’s disease: a survey of 459 patients treated at one institution
1998 · European Journal of Cancer · 70 citations
https://doi.org/10.1016/s0959-8049(98)00269-x
Gonadal function in male patients after treatment for malignant lymphomas, with emphasis on chemotherapy
2009 · British Journal of Cancer · 61 citations
https://doi.org/10.1038/sj.bjc.6604892
MicroRNAs regulate key cell survival pathways and mediate chemosensitivity during progression of diffuse large B-cell lymphoma
2017 · Blood Cancer Journal · 35 citations
https://doi.org/10.1038/s41408-017-0033-8
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat